Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Rhea-AI Summary

Avenue Therapeutics (Nasdaq: ATXI), a specialty pharmaceutical company, will participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference. The company's CEO, Dr. Alexandra MacLean, will present at the event. The presentation will be accessible to registered attendees on-demand starting on Thursday, June 27, 2024, at 7:00 a.m. ET. Avenue Therapeutics focuses on developing and commercializing therapies for neurologic diseases.

MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that Alexandra MacLean, M.D., Chief Executive Officer of Avenue Therapeutics, will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference. The presentation will be available to registered attendees for on-demand viewing on Thursday, June 27, 2024 starting at 7:00 a.m. ET.

About Avenue Therapeutics
Avenue Therapeutics, Inc. (Nasdaq: ATXI) is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases. It is currently developing three assets including AJ201, a first-in-class asset for spinal and bulbar muscular atrophy, BAER-101, an oral small molecule selective GABA_A α2, α3 receptor positive allosteric modulator for CNS diseases, and IV tramadol, which is in Phase 3 clinical development for the management of acute post-operative pain in adults in a medically supervised healthcare setting. Avenue is headquartered in Miami, FL and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). For more information, visit www.avenuetx.com.

Contact:
Jaclyn Jaffe
Avenue Therapeutics, Inc.
(781) 652-4500
ir@avenuetx.com

FAQ

What event will Avenue Therapeutics present at?

Avenue Therapeutics will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference.

When will Avenue Therapeutics' presentation be available?

The presentation will be available on-demand starting Thursday, June 27, 2024, at 7:00 a.m. ET.

Who is presenting for Avenue Therapeutics at the H.C. Wainwright conference?

Dr. Alexandra MacLean, CEO of Avenue Therapeutics, will be presenting.

What is the focus of Avenue Therapeutics?

Avenue Therapeutics focuses on the development and commercialization of therapies for neurologic diseases.

What is the stock symbol for Avenue Therapeutics?

The stock symbol for Avenue Therapeutics is ATXI.